25riskM

Market Quick Take - July 6, 2020

Macro 3 minutes to read

Summary:  Asian stocks, led by Chinese equities, rose overnight following positive comments on the market from Chinese state media. Benchmarks across the region followed while U.S. remain bid, thereby supporting risk appetite across other markets such as crude oil. It highlights the markets ability and willingness to look through rising infection rates towards an anticipated recovery. The dollar trades softer as the euro mount another upside challenge. A thin week in terms of economic news will give the market plenty of time to prepare for the U.S. earnings season, kicking of next week.


What is our trading focus?

  • US500.I (S&P 500 Index) and USNAS100.I (NASDAQ 100 Index) – the S&P 500 is starting the week pushing above the intermediate local highs from 16 June around the 3,156 level which happened during the initial rebound from the sharp selloff on 11 June. This is technically a strong short-term momentum setup for pushing towards the highs from 8 June around 3,231. The Nasdaq 100 pushed briefly beyond 10,500 in early trading continuing its ascent despite record high valuations in the Nasdaq Composite Index.

  • OILUSAUG20 (WTI) OILUKSEP20 (Brent) - both challenging resistance with the continued bid in stocks providing most of the short-term inspiration. The fundamental stalemate between virus related demand worries and OPEC+ production cuts, has driven volatility – using Average True Range (ATR) - down to January levels. Focus this week will be the monthly overview of the worldwide oil market from the IEA on Thursday. EIA’s weekly report on Wednesday will be watched closely for any signs of a renewed slowdown in fuel demand. This as the number of new virus cases rise across the most populous U.S. states. A Brent break above $44/b would likely trigger an attempt to close the gap to $45.18/b.

  • EURUSD - is following crude oil and equities higher this morning setting it up for a test 1.1300 which turned out to be a strong resistance level last week. Comments over the weekend from ECB’s Villeroy that the French recovery looks better than expected is also fueling EUR sentiment.

  • BNK:xpar (European banks) - focus on European banks today after last week’s momentum ending Friday a bit lower and just below the 100-day moving average which was also the key resistance level back at the local highs on 8 June. A firm break above this moving average today could see European banks higher over the week.

What is going on?

  • Asia equities starting the week on a strong note with Chinese equities up 6.7% driven by a bullish front-page editorial in the state-run Chinese Securities Journal extending sentiment off last week’s strong Caixin Services Index reading of 58.4. Retail investors dominating the Chinese equity market are buying the story about the prospects for a healthy bull market. The strong move in Chinese equities seems to be cascading into other markets such as developed equities and crude oil.

  • COVID-19 infections in the US continue rise over the weekend with signs of acceleration in hospitalizations and daily deaths across the Sun Belt risking the reopening of these economies. Other countries such as Japan and Australia have recently seen a resurgence in daily infections and India’s 7-day average daily infections continue to rise.

  • German Factory Orders in May down 29.3% y/y which was worse than expected highlighting the impact from the slowdown in global activity from lockdowns in Q2.

  • Coronavirus related developments have sent two growth dependent commodities in opposite directions. Cocoa has slumped back below $2200/t on worries that the pandemic will weaken chocolate demand at a time when there is expected to be ample supply coming from West Africa. HG copper meanwhile has almost erased the losses for the year, currently trading at $2.75/lb. Strong demand from China supported the rally during the early stages. During the past few weeks however the spreading of the virus has started to impact supplies from the world’s biggest production areas in South America.

What we are watching next?

  • Whether the COVID-19 resurgence extends to hospitalizations and a rise in daily deaths. The US had its worst weekend in terms daily infections with ICU capacity becoming critical in many hotspots across the Sun Belt states such as Arizona, Texas and Florida.

  • ISM Non-Manufacturing for June is published today with expectations looking for 50.0 reading up from 45.4 in May suggest that the services sector in the US is still struggling at much lower activity levels.

  • Q2 earnings season starts next week which will be the most exciting in many years as 80% of S&P 500 companies skipped their guidance in Q1 leaving investors to fly blind into the storm. With US technology stock valuations at record levels there is little margin for error so any revenue miss could lead to steep declines.

  • The market failed to take note of several failed COVID-19 trials last week with both Moderna and Regeneron issuing negative statements. Regeneron and Sanofi said their US Phase 3 trial was not a success against the placebo benchmark and Moderna was rumoured to have seen delays in its study.

  • Corn traders will look towards the World Agriculture Demand & Supply (WASDE) report on July 10 for confirmation that the recent 10% rally can be sustained. Will the smaller than expected planted acreage announced recently be enough to make up for declining demand from ethanol producers thereby helping to keep inventories under control.

Economic Calendar Highlights (times GMT)

  • 14:00 – U.S. ISM Non-manufacturing Index
  • 19:15 – CFTC Commitments of Traders report, delayed release from Friday due to U.S. holiday

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.